ResMed [RMD] vs Intuitive Surgical [ISRG] Detailed Stock Comparison

ResMed Inc.

NYSE
Loading...

Intuitive Surgical, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: ResMed Inc. wins in 13 metrics, Intuitive Surgical, Inc. wins in 7 metrics, with 0 ties. ResMed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric ResMed Inc. Intuitive Surgical, Inc. Better
P/E Ratio (TTM) 21.69 54.97 ResMed Inc.
Price-to-Book Ratio 5.06 8.99 ResMed Inc.
Debt-to-Equity Ratio 13.41 0.95 Intuitive Surgical, Inc.
PEG Ratio 1.50 3.30 ResMed Inc.
EV/EBITDA 15.51 43.46 ResMed Inc.
Profit Margin (TTM) 27.53% 28.38% Intuitive Surgical, Inc.
Operating Margin (TTM) 35.16% 30.16% ResMed Inc.
EBITDA Margin (TTM) 35.16% 30.16% ResMed Inc.
Return on Equity 25.68% 16.69% ResMed Inc.
Return on Assets (TTM) 14.75% 9.39% ResMed Inc.
Free Cash Flow (TTM) $1.65B $2.49B Intuitive Surgical, Inc.
Dividend Yield 0.92% N/A N/A
1-Year Return -21.88% -19.74% Intuitive Surgical, Inc.
Price-to-Sales Ratio (TTM) 5.92 15.93 ResMed Inc.
Enterprise Value $31.41B $154.62B Intuitive Surgical, Inc.
EV/Revenue Ratio 5.82 15.36 ResMed Inc.
Gross Profit Margin (TTM) 61.76% 66.44% Intuitive Surgical, Inc.
Revenue per Share (TTM) $37 $28 ResMed Inc.
Earnings per Share (Diluted) $10.12 $8.21 ResMed Inc.
Beta (Stock Volatility) 0.93 1.68 ResMed Inc.
Short % of Float 9.40% 1.91% Intuitive Surgical, Inc.

ResMed Inc. vs Intuitive Surgical, Inc. Stock Performance Analysis

Loading Price Chart...

RMD
ISRG

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
ResMed Inc.-1.05%-0.21%-4.53%-16.42%-23.84%-21.27%
Intuitive Surgical, Inc.1.34%-0.49%-1.09%-13.84%-25.55%-25.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
ResMed Inc.-21.88%-11.08%-17.97%233.76%527.92%775.81%
Intuitive Surgical, Inc.-19.74%24.81%40.32%476.52%974.11%3,431.44%

Performance & Financial Health Analysis: ResMed Inc. vs Intuitive Surgical, Inc.

MetricRMDISRG
Market Information
Market Cap i$32.03B$170.06B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i955,8422,113,347
90 Day Avg. Volume i1,020,5541,799,766
Last Close$192.74$416.55
52 Week Range$180.27 - $293.81$396.68 - $603.88
% from 52W High-34.40%-31.02%
All-Time High$301.34 (Sep 06, 2021)$616.00 (Jan 20, 2025)
% from All-Time High-36.04%-32.38%
Growth Metrics
Quarterly Revenue Growth0.11%0.19%
Quarterly Earnings Growth0.14%0.16%
Financial Health
Profit Margin (TTM) i0.28%0.28%
Operating Margin (TTM) i0.35%0.30%
Return on Equity (TTM) i0.26%0.17%
Debt to Equity (MRQ) i13.410.95
Cash & Liquidity
Book Value per Share (MRQ)$43.39$50.19
Cash per Share (MRQ)$9.73$16.71
Operating Cash Flow (TTM) i$1.91B$3.03B
Levered Free Cash Flow (TTM) i$1.42B$2.27B
Dividends
Last 12-Month Dividend Yield i0.92%N/A
Last 12-Month Dividend i$2.33N/A

Valuation & Enterprise Metrics Analysis: ResMed Inc. vs Intuitive Surgical, Inc.

MetricRMD (Apr 26, 2026)ISRG (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i21.6954.97
Forward P/E i18.0239.49
PEG Ratio i1.503.30
Price to Sales (TTM) i5.9215.93
Price to Book (MRQ) i5.068.99
Market Capitalization
Market Capitalization i$32.03B$170.06B
Enterprise Value i$31.41B$154.62B
Enterprise Value Metrics
Enterprise to Revenue i5.8215.36
Enterprise to EBITDA i15.5143.46
Risk & Other Metrics
Beta i0.931.68
Book Value per Share (MRQ) i$43.39$50.19

Financial Statements Comparison: ResMed Inc. vs Intuitive Surgical, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRMD (2025)ISRG (2025)
Revenue/Sales i5.15B10.06B
Cost of Goods Sold i2.09B3.42B
COGS % of Revenue i40.6%34.0%
Gross Profit i3.05B6.64B
Gross Margin i59.4%66.0%
Research & Development i331.28M1.31B
Operating Income (EBIT) i1.69B2.95B
Operating Margin i32.8%29.3%
EBITDA i1.93B3.62B
EBITDA Margin i37.4%36.0%
Pre-Tax Income i1.68B3.31B
Pre-Tax Income % of Revenue i32.6%32.9%
Income Tax i276.84M434.80M
Income Tax % of Revenue i5.4%4.3%
Net Income (Profit) i1.40B2.88B
Profit Margin i27.2%28.6%

Balance Sheet & Liquidity Metrics

MetricRMD (2025)ISRG (2025)
Cash & Equivalents i1.21B3.37B
Total Current Assets i3.51B9.78B
Total Current Assets % of Revenue i68.1%97.2%
Total Current Liabilities i1.02B2.01B
Total Current Liabilities % of Revenue i19.8%19.9%
Long-Term Debt i811.41MN/A
Long-Term Debt % of Revenue i15.8%0.0%
Total Shareholders Equity i5.97B17.94B
Retained Earnings i6.08B7.01B
Retained Earnings % of Revenue i118.2%69.7%
Property, Plant & Equipment i288.62M2.10B

Cash Flow Statement Comparison

MetricRMD (2025)ISRG (2025)
Operating Cash Flow i1.57B3.28B
Operating Cash Flow % of Revenue i30.5%32.5%
Capital Expenditures i-89.87M-539.80M
Free Cash Flow i1.65B2.49B
FCF Margin i32.1%24.7%
Debt Repayment i-40.00MN/A
Common Stock Repurchase i-300.03M-2.30B

Short Interest & Institutional Ownership Analysis

MetricRMDISRG
Shares Short i11.89M6.75M
Short Ratio i11.244.19
Short % of Float i9.40%1.91%
Shares Outstanding i145.66M355.10M
Float Shares i144.79M352.94M
% Held by Insiders i0.50%0.56%
% Held by Institutions i68.82%89.20%
% Held by Public i30.68%10.24%

Dividend Analysis & Yield Comparison: ResMed Inc. vs Intuitive Surgical, Inc.

MetricRMDISRG
Last 12-Month Dividend i$2.33N/A
Last 12-Month Dividend Yield i0.92%N/A
3-Year Avg Annual Dividend i$2.09N/A
3-Year Avg Dividend Yield i0.24%N/A
3-Year Total Dividends i$6.28N/A
Ex-Dividend DateFeb 12, 2026N/A